Study of Automated Care Pathway for Patients With Chronic Obstructive Pulmonary Disease (COPD) (EPICPath)
Early Patient Identification and Care Pathway for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial of Informatics Enhanced Hospital Admission
Sponsor: University of California, San Francisco
Terminated
Trend toward increased readmissions in the auto-delivery arm.
Other terminated trials from University of California, San Francisco
- Hypertension · Phase PHASE2 · Jan 2026
- Menstrual Irregularity · Phase PHASE4 · Sep 2025
- Diabetes Mellitus, Type 2 · Phase NA · Feb 2025
- Asthma · Phase PHASE4 · Feb 2025
- Stone, Kidney · Phase NA · Dec 2024
See all terminations from University of California, San Francisco
Other Pulmonary Disease, Chronic Obstructive trials with similar outcome
Listed as NCT03028805, this NA trial focuses on Pulmonary Disease, Chronic Obstructive and Pulmonary Diseases, Obstructive and remains terminated or withdrawn. Sponsored by University of California, San Francisco, it has been updated 6 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jul 2019 — Jan 2021 [monthly]
Terminated NA
Status: Enrolling By Invitation → Terminated
-
Jun 2018 — Jul 2019 [monthly]
Enrolling By Invitation NA
Status: Not Yet Recruiting → Enrolling By Invitation
▶ Show 1 earlier version
-
Feb 2017 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .